The Future of the Behavioral Health Workforce: Optimism and Opportunity

Beck, Angela J.; Manderscheid, Ronald W.; Buerhaus, Peter I.

doi:10.1016/j.amepre.2018.03.004

Cited by 25 publications

(19 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In addition, psychotherapies such as interpersonal psychotherapy and cognitive behavioral therapy have been shown to be effective in treating perinatal depression [ 45 ]. Structural barriers often limit access to these effective treatments, with lack of health insurance coverage and limited workforce capacity in mental health being significant contributors [ 46 , 47 ]. Addressing barriers, in addition to creating multidisciplinary care models to deliver family-centered care for pregnant or postpartum women with HIV, shows promise in improving maternal outcomes [ 48 ].…”

Section: Discussionmentioning

confidence: 99%

Perinatal Depressive Symptoms, Human Immunodeficiency Virus (HIV) Suppression, and the Underlying Role of Antiretroviral Therapy Adherence: A Longitudinal Mediation Analysis in the IMPAACT P1025 Cohort

Momplaisir

Hussein

Kacanek

et al. 2021

Clinical Infectious Diseases

View full text Add to dashboard Cite

Background Women with HIV have higher risk of depressive symptoms in the perinatal period. Evidence on how perinatal depressive symptoms affect viral suppression (VS) and adherence to antiretroviral therapy (ART) remains limited. Methods Perinatal depressive symptoms were assessed using 6 items from the AIDS Clinical Trials Group (ACTG) Quality of Life questionnaire. VS (viral load <400 copies/mL) was the outcome. Adherence was defined as no missed dose in the past 1-4 weeks using the ACTG Adherence Questionnaire. Generalized, mixed-effects structural equation models estimated the association of depressive symptoms on VS and the mediating role of ART adherence among women enrolled in the IMPAACT P1025 Perinatal Core Protocol (2002-2013). Results Among 1,869 participants, 47.6% were 21-29 years-old, 57.6% non-Hispanic Black. In the 3 rd trimester, the mean depressive symptoms score was 14.0 (±5.2), 68.0% had consistent adherence, and 77.3% achieved VS. At 6 months postpartum, depressive symptoms declined while adherence and VS fell to 59.8% and 53.0%, respectively. In the fully-adjusted model, a 1-SD increase in depressive symptoms was associated with a 3.8-percentage-point [95%Cl: -5.7,-1.9] decline in VS. This effect is the sum of the indirect effect of depressive symptoms on VS via ART adherence (-0.4 [95%CI: -0.7,-0.2]) and the direct effect through other pathways (-3.4 [95%CI: -5.2,-1.5]). The decline in adherence driven by depressive symptoms accounted for ≥11% of the total negative effect of depressive symptoms on VS. Conclusion Perinatal depressive symptoms were associated with decreased adherence and VS, highlighting the need to screen for, diagnose, and treat perinatal depression to optimize maternal outcomes.

show abstract

Section: Discussionmentioning

confidence: 99%

Perinatal Depressive Symptoms, Human Immunodeficiency Virus (HIV) Suppression, and the Underlying Role of Antiretroviral Therapy Adherence: A Longitudinal Mediation Analysis in the IMPAACT P1025 Cohort

Momplaisir

Hussein

Kacanek

et al. 2021

Clinical Infectious Diseases

View full text Add to dashboard Cite

show abstract

“…In the context of the opioid epidemic, there are ongoing concerns of shortages of buprenorphine prescribers [12, 42, 43] and behavioral health providers [44–46]. Physician satisfaction can be the driver of the use of evidence-based practices and physician retention [25].…”

Section: Discussionmentioning

confidence: 99%

Physicians’ satisfaction with providing buprenorphine treatment

Knudsen

Brown

Jacobson

et al. 2019

Addict Sci Clin Pract

View full text Add to dashboard Cite

Background Buprenorphine is a critically important treatment for addressing the opioid epidemic, but there are virtually no studies of physicians’ job satisfaction with providing buprenorphine. Physicians’ job satisfaction has been linked to burnout and turnover as well as patients’ adherence to treatment recommendations, so it is important to understand how physicians’ satisfaction with providing buprenorphine treatment compares to their overall job satisfaction. Methods As part of a cluster randomized clinical trial (RCT) focused on expanding access to medication for opioid use disorder, 55 physicians working in 38 organizations in Florida, Ohio, and Wisconsin completed a baseline web-based survey. Study measures included global job satisfaction, career satisfaction, and specialty satisfaction. Physicians who were waivered to prescribe buprenorphine were asked to rate their satisfaction with their current buprenorphine practice. Results Overall, physicians were generally satisfied with their jobs, their careers, and their specialties. When waivered physicians (n = 40) were compared to non-waivered physicians (n = 15) on 13 satisfaction items, there were no statistically significant differences. Among waivered physicians, ratings for buprenorphine work were significantly lower than ratings for general medical practice for finding such work personally rewarding, being pleased with such work, and overall satisfaction. Conclusions Although waivered and non-waivered physicians both reported high global job satisfaction, these data suggest that some waivered physicians may view their buprenorphine work as somewhat less satisfying than their global medical practice. Given that job dissatisfaction is a risk factor for turnover and burnout, managers of treatment organizations should consider whether strategies may be able to mitigate some sources of lower satisfaction in the context of buprenorphine treatment. Trial registration ClinicalTrials.gov. NCT02926482. Date of registration: September 9, 2016. https://clinicaltrials.gov/ct2/show/NCT02926482

show abstract

“…Social workers are the largest group of clinically trained behavioral health providers in the United States (Anxiety and Depression Association of America [ADAA], n.d.). This profession is projected to grow globally as demand increases (Beck et al, 2018). mHealth has been identified as a promising tool to reach isolated populations for supporting health assessment, treatment, and client engagement to behavioral health care and social services (Seko et al, 2014).…”

Section: Mobile Apps In Social Work Practicementioning

confidence: 99%

Using mobile apps in social work behavioral health care service: The case for China

Chow

Pathak

Yeh

2021

International Social Work

View full text Add to dashboard Cite

Mobile apps have increasingly become an innovative tool that can provide information and resources to those who have service needs but often lack access to and knowledge about how to improve their well-being in today’s society. In China, although the number of Internet users has increased substantively, there has been little discussion on how mobile apps can help social workers in their delivery of behavioral health services. This article features three highly used apps that facilitate behavioral health care service delivery in the United States and provides recommendations for developing apps for social work practice in China.

show abstract

The Future of the Behavioral Health Workforce: Optimism and Opportunity

Cited by 25 publications

References 14 publications

Perinatal Depressive Symptoms, Human Immunodeficiency Virus (HIV) Suppression, and the Underlying Role of Antiretroviral Therapy Adherence: A Longitudinal Mediation Analysis in the IMPAACT P1025 Cohort

Perinatal Depressive Symptoms, Human Immunodeficiency Virus (HIV) Suppression, and the Underlying Role of Antiretroviral Therapy Adherence: A Longitudinal Mediation Analysis in the IMPAACT P1025 Cohort

Physicians’ satisfaction with providing buprenorphine treatment

Using mobile apps in social work behavioral health care service: The case for China

Contact Info

Product

Resources

About